Santus Laboratories (owned by HealthEdge Partners) manufactures and sells dermatology products to the institutional market, including hospitals and long-term care. Santus’ key product is a proprietary and highly regarded product, Boroleum.
Boroleum was purchased by Reliable1. Relaible1 acquired the right to manufacture, market and sell Boroleum. Boroleum will enable Reliable1 to extend their product portfolio and provide a differentiated product to the institutional market.
This will provide Reliable1 the ability to market a differentiated and growing cough-cold product.
Crosstree acted as sole advisor to Santus/Healthedge.